Reference health

Mendelian Randomization Study on the Effect of Tumour Necrosis Factor on Schizophrenia

https://doi.org/10.2139/ssrn.3989863
CiteStamped reference-health badge
28/28 checkable references clean · checked 2026-08-29

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 28 checked references that resolve
resolves10.1016/j.schres.2014.07.025
Neuroimmune biomarkers in schizophrenia
resolves10.1177/070674379704200204
Epidemiology of Schizophrenia
resolves10.3390/ijms14059037
Role of Melatonin in Schizophrenia
resolves10.1016/bs.adgen.2016.08.001
Genetics of Schizophrenia
resolves10.3389/fpsyt.2020.00160
The Role of Inflammation in the Treatment of Schizophrenia
resolves10.1016/j.jneuroim.2020.577344
The association between serum levels of TNF-α and IL-6 in schizophrenic patients and their metabolic status – A case control study
resolves10.1038/mp.2016.3
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
resolves10.1016/j.bbi.2021.07.009
Associations of immunological proteins/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization study
resolves10.1016/j.bbi.2017.11.020
Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort
resolves10.1001/jamapsychiatry.2017.3191
Inflammatory Biomarkers and Risk of Schizophrenia
resolves10.1016/j.arcmed.2018.09.007
Promoter Polymorphisms of TNF-α Gene as a Risk Factor for Schizophrenia
resolves10.1016/j.comppsych.2019.01.003
Changes in serum TNF-α, IL-18, and IL-6 concentrations in patients with chronic schizophrenia at admission and at discharge
resolves10.1016/S2215-0366(16)30366-2
Monoclonal antibody immunotherapy in psychiatric disorders
resolves10.1002/sim.3034
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
resolves10.1371/journal.pmed.1001866
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
resolves10.1016/j.ebiom.2020.102956
Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study
resolves10.1038/nature12873
Genetics of rheumatoid arthritis contributes to biology and drug discovery
resolves10.1038/ng.3760
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
resolves10.1038/nature13595
Biological insights from 108 schizophrenia-associated genetic loci
resolves10.1038/s41588-018-0099-7
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
resolves10.1002/sim.6522
Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome
resolves10.1007/s12017-013-8225-2
PICALM Gene rs3851179 Polymorphism Contributes to Alzheimer’s Disease in an Asian Population
resolves10.1093/ije/dyr036
Avoiding bias from weak instruments in Mendelian randomization studies
resolves10.1016/j.psyneuen.2017.12.024
Interaction between BDNF and TNF-α genes in schizophrenia
resolves10.1016/j.bbr.2020.112832
Association of circulating BDNF levels with BDNF rs6265 polymorphism in schizophrenia
resolves10.1007/7854_2018_88
Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia
resolves10.1016/j.bbi.2019.06.002
Psychosis as an adverse effect of monoclonal antibody immunotherapy
resolves10.1177/1352458517737373
Mendelian randomization in multiple sclerosis: A causal role for vitamin D and obesity?
The 2 references without a DOI — listed, not checked
no DOI — not checkedref3
no DOI — not checkedInteraction between TNF-alpha and oxidative stress status in first-episode drug-naive schizophrenia
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-29 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.3989863"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3989863/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.3989863/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.3989863)